March 3, 2026March 3, 2026 Natco Pharma Ltd said on Tuesday, 3 March, that it and its partner Breckenridge Pharmaceutical have introduced Pomalidomide capsules, a generic version of Celgene’s Pomalyst, in the United States. The capsules, a thalidomide analogue, are indicated for the treatment of adult patients with multiple…
February 13, 2026February 13, 2026 Shares of Natco Pharma Ltd were trading in the red and 2% lower on 13 February after the company announced that the US drug authority had issued seven Form 483 observations for the company’s Chennai API unit. The business stated…
November 24, 2025November 24, 2025 Shares of Natco Pharma Ltd were trading 2% lower on 24 November after the company announced receiving 7 observations from the United States Food and Drug Administration. The USFDA completed the inspection at the company’s Manali, Chennai, Active Pharmaceutical Ingredients (API) unit, which took…
October 17, 2025October 17, 2025 Shares of Natco Pharma Ltd were trading 3% higher on Friday, 17 October, after the Supreme Court (SC) quashed a plea from Roche, which was challenging the interim Delhi High Court Order for rolling out the generic version of the…
September 18, 2025September 18, 2025 Shares of Natco Pharma Ltd surged 3% on Thursday, 18 September, after the company announced that its unit in Hyderabad received EIR from the USFDA. According to the most recent regulatory filings, NATCO Pharma Limited revealed that the United States Food and Drug Administration…
June 20, 2025June 20, 2025 Shares of Natco Pharma Ltd were trading in the red and 1% lower on 20 June after the company received seven Form-483 observations from the US Food and Drug Administration (USFDA). The firm reported the completion of a USFDA inspection at its pharmaceutical division…